What Changed
Price Move History
- Daily moves over 5%
- 0 25 sessions, October 13, 2025 to October 22, 2026
- Largest daily move
- -3.4% close of October 27, 2025
- 1-year change
- -2.4% closing prices, October 13, 2025 to October 22, 2026
Company Description
Oaktree Acquisition III Life Sciences Unit (NASDAQ: OACCU) is classified in the shell companies industry within the Financial Services sector.
OACCU has declined 2.4% over the past year. The last closing price was $10.80.
For FY2025, Oaktree Acquisition III Life Sciences Unit reported net income of $7.3M.
This page collects what Stock Titan holds for OACCU, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Oaktree Acquisition III Life Sciences Unit (OACCU) closed at $10.80 on October 22, 2026. Over the past 12 months, the price has lost 2.4%.
OACCU Metrics & Rankings
Price returns through October 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Oaktree Acquisition III Life Sciences Unit has 2 recent news articles. Key topics include acquisition, IPO, offering. View all OACCU news →
SEC Filings
Oaktree Acquisition III Life Sciences Unit has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G, 2 Form 8-K, 2 Form 10-Q, 1 Form DEF 14A. The most recent filing was submitted on October 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OACCU SEC filings →
Financial Highlights
operating income reached -$1.2M, and net income was $7.3M. The company generated -$422K in operating cash flow. The current ratio was 1.19, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Oaktree Acquisition III Life Sciences Unit (OACCU) currently stands at 1.9 thousand shares, down 0.3% from the previous reporting period. Since October 2025, short interest has decreased by 44.6%.
Days to Cover History
Days to cover for Oaktree Acquisition III Life Sciences Unit (OACCU) currently stands at 971.5 days, up 99.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 1672.8%. Across the settlements charted above, it has ranged from 1.8 to 1000.0 days.
OACCU Company Profile & Sector Positioning
Oaktree Acquisition III Life Sciences Unit (OACCU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing OACCU often look at related companies in the same sector, including Aimei Health Technology Co., Ltd Unit (AFJKU), Aldel Financial II Inc. Units (ALDFU), Bayview Acquisition Corp Unit (BAYAU), Cayson Acquisition Corp Unit (CAPNU), and Future Vision II Acquisition Corporation Units (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OACCU's relative position within its industry.